AlphaStocks
7.1
Consider Buy

UNITED THERAPEUTICS Corp (UTHR)

Health Care / Biotechnology

S&P MidCap 400

$570.32

Above average across most dimensions. A solid candidate.

Consider Buy

Score based on 5 of 5 models — high confidence

#84out of 1127 in Health Care

Is UNITED THERAPEUTICS Corp a Good Investment in 2026?

UNITED THERAPEUTICS Corp (UTHR) scores 7.1 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates UNITED THERAPEUTICS Corp as Strong (7/9). The Graham model is the least favorable, rating it Neutral. UNITED THERAPEUTICS Corp currently trades below its estimated fair value of $860, suggesting potential upside. UNITED THERAPEUTICS Corp ranks #84 out of 1127 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E20.5ROE15.9Market Cap27B

Estimated Fair Value

$859.8134% below

Fair value above market price. P/E of 20x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

56% above fair value

Lynch

Strong

PEG 0.6 · Fast Grower

Greenblatt

Attractive

Top half (rank 36%)

Frequently Asked Questions

Is UNITED THERAPEUTICS Corp (UTHR) a good investment?
Based on AlphaStocks' composite analysis, UNITED THERAPEUTICS Corp (UTHR) scores 7.1 out of 10, earning a Consider Buy rating. This places it above average across most investment dimensions. Fair value above market price. P/E of 20x is moderate for this quality level.
What is UNITED THERAPEUTICS Corp's Piotroski F-Score?
UNITED THERAPEUTICS Corp's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is UTHR overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $860, UTHR appears undervalued. The stock currently trades 34% below its estimated fair value. Fair value above market price. P/E of 20x is moderate for this quality level.
How does UTHR compare to other Health Care stocks?
UNITED THERAPEUTICS Corp ranks #84 out of 1127 stocks in the Health Care sector, placing it in the top 7% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about UTHR?
AlphaStocks evaluates UTHR using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Neutral; Lynch: Strong; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 7.1/10.

Similar Stocks

PARRFTIAZN

Compare UTHR with

UTHR vs PARRUTHR vs FTIUTHR vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer